U.S. federal trademark · Serial No. 76673491 · Reg. No. 3289154
Medical services, namely, performing innovative clinical trials and evaluating new agents and new treatment strategies in patients with advanced cancer, with the results being presented at scientific meetings and published in medical literature
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.